Condition
Creatine Kinase
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07356193Not ApplicableCompleted
Serum CPK and Creatinine Changes During Plyometric Training in Collegiate Athletes
NCT07046598Not ApplicableCompleted
Is The Level of Muscle Damage After The Drop Jump Protocol Affected By Body Weight and BMI?
NCT04838509CompletedPrimary
Diagnoses Associated With Persistent Elevation of Creatine Kinase
NCT03163719Unknown
Impact of Early Lactate Dosage Compared to CK for Diagnosis of a Suspected Seizure
Showing all 4 trials